相关实验视频
Updated: Sep 19, 2025

08:01
The Soft Agar Colony Formation Assay
Published on: October 27, 2014
112.3K
调节Wnt/β-catenin通路活性,以增强胆管癌中的化学敏感性
Kevin Delgado-Calvo1, Luke Boulter2, Oscar Briz1
1Experimental Hepatology and Drug Targeting (HEVEPHARM), Institute for Biomedical Research of Salamanca (IBSAL), University of Salamanca, Salamanca, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Carlos III National Institute of Health, Madrid, Spain.
概括
向Wnt/β-catenin通路可以克服胆管癌 (CCA) 中的化学抵抗. 将Wnt/β-catenin抑制剂与化疗相结合,有望改善CCA患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 胆管癌 (CCA) 由于化学抵抗机制,表现出化学疗法反应不佳.
- 在CCA中,Wnt/β-catenin通路过度激活,并且与增殖,迁移和血管生成有关.
- 这一途径可能会对CCA化学抵抗产生重大影响.
研究的目的:
- 研究Wnt/β-catenin在CCA多药耐药性中的作用.
- 探索结合化疗与Wnt/β-catenin抑制剂的治疗潜力.
主要方法:
- 在体外测试中,使用CCA细胞系治疗了Wnt/β-catenin抑制剂 (C59,XAV939,PRI724).
- 通过TLDA,RT-qPCR和Western Blot对Wnt目标基因和化学抗药基因的评估.
- 在体内研究中,使用化学诱导的CCA与PRI724和5-FU治疗的老鼠进行了实验.
主要成果:
- 抑制Wnt/β-catenin通路 (通过沉默或抑制剂) 下调目标基因和改变化学抵抗基因表达.
- 在PRI724与化疗药物的联合治疗中,在试验室中显示了减少细胞增殖的附加效应.
- 与PRI724和5-FU的联合治疗在体内显著减少了瘤大小.
结论:
- 抑制Wnt/β-catenin通路通过调节化学抵抗基因表达来使CCA细胞具有化学敏感性.
- 将Wnt/β-catenin抑制剂与化疗相结合提供了一个有前途的策略,以提高CCA患者的治疗结果.
相关概念视频
Canonical Wnt Signaling Pathway
9.0K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.0K
Non-Canonical Wnt Signaling Pathways
7.4K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Catenins
2.5K
Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.5K

